Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton therapy targeting hypoxic cells in skull base and spine chordomas using [18F]FAZA PET/CT
2015-003806-18Phase 2Completed
- Sponsor
- Institut Curie
- Start
- Apr 2016
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluoromisonidazole in Skull base chordoma (SBC) and chordoma, sponsored by Institut Curie. Primary endpoint: Local control. Started Apr 2016; status: completed.
02
Drugs
fluoromisonidazole
03
Conditions
Skull base chordoma (SBC)chordoma
Beyond the preview
Go deeper on 2015-003806-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003806-18.